Ocuphire Management TeamDecades of Biotech and Drug Development Experience Mina
Sooch, MBA Chief Executive Officer 25 years in pharma/biotech industry as a CEO, entrepreneur, venture capitalist and strategist. Raised over 100 million dollars for 2 biotechs, then led private to public on Nasdaq, Recognized as MI
Newsmaker of the Year. Konstantinos Charizanis, PhD, MBA Senior Director of Market Strategy and R&D Drey ColemanDirector Clinical Operations and Vendor Management Charlie Hoffmann, MBAVP Corporate Development and
Operations 25 years in life sciences fundraising, corporate finance, licensing and M&A transactions, and corporate development, Long time advisor to Ocularis/Nyxol. 14 years in medical research, product development, market research,
and biotech business development, with a focus on financial modeling, patents and genetics. 15 years in ophthalmic pharmaceutical research and development as sponsor and CRO with a focus on clinical operations, vendor management, pharma
regulations, and successful contract negotiations. 18 years in finance and accounting, for private and public companies, with a focus on life sciences. Held progressive roles including Controller, Director of Finance, and acting
CFO. Amy Rabourn, CPA VP Finance 4